Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for Marijuana Addiction
NCT00217971Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Mar 2005
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cannabis use disorder (CUD) comparing Dronabinol with Placebo (2 arms). Primary endpoint: Proportion of Patients Abstinent From Marijuana During Weeks 7 and 8 of the Trial. Started Mar 2005; status: completed.
02
Drugs
dronabinol
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00217971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217971.